0001193125-17-176606 Sample Contracts

GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
Galectin Therapeutics Inc • May 19th, 2017 • Pharmaceutical preparations • New York

Galectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with FBR Capital Markets & Co. (“FBR”), as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.